Smart diapers protect dignity in dementia care by reducing “open-and-check” inspections, so people aren’t exposed. They prioritize fast response to bowel movements and help protect sleep and comfort, reducing BPSD triggers.
#DementiaCare #CareTech #IncontinenceCare #BPSD #AgingTech
31.01.2026 23:50 — 👍 1 🔁 0 💬 1 📌 0
Tracing the Evolution of Dementia Villages: From De Hogeweyk to Agrace
Dementia care has been shifting from “managing people for safety” to “building environments where a person can keep living.” A dementia…
Dementia care is shifting from “control for safety” to designing places where people can keep living ordinary lives.
I trace how dementia villages evolved—from De Hogeweyk to diverse global versions—into a broader, neighborhood-style approach.
#DementiaVillage
medium.com/@kosaku.okam...
28.01.2026 07:27 — 👍 0 🔁 0 💬 0 📌 0
An AI That Predicts Dementia Progression from Clinical Notes: What “Dementia-R1” Could Mean
In early January 2026, a new AI approach drew attention for a simple reason: it aims to anticipate dementia progression earlier than we…
Clinical notes include signs like “missed meds,” “can’t manage money,” or “more bad days.” A new AI (Dementia-R1, Jan 2026) uses these notes—not just test scores—to flag faster decline earlier, helping families and care teams plan sooner.
medium.com/@kosaku.okam...
16.01.2026 02:48 — 👍 0 🔁 0 💬 0 📌 0
Alzheimer’s Disease and APOE: How Genetics May Point to New Treatment Directions
In January 2026, reports suggested that APOE, a gene long discussed in Alzheimer’s research, may be involved in a larger share of…
Jan 2026: APOE is back in focus for Alzheimer’s.
Beyond ε4, even common ε3 may influence risk.
Because APOE affects lipids, inflammation, and vascular health, it may open therapy paths beyond amyloid.
medium.com/@kosaku.okam...
15.01.2026 16:32 — 👍 0 🔁 0 💬 0 📌 0
ChatGPT Health and Claude for Healthcare：What Will “AI-Mediated Healthcare” Change?
In January 2026, the two major players in generative AI successively announced their “healthcare-specific” directions. One is OpenAI’s…
Jan 2026: ChatGPT Health + Claude for Healthcare highlight “AI-mediated care.” One translates records (RAG/FHIR); the other prioritizes safety (Constitutional AI). The shift isn’t automated diagnosis—it’s better prep and clearer patient-clinician conversations.
medium.com/@kosaku.okam...
13.01.2026 06:48 — 👍 1 🔁 0 💬 0 📌 0
AI Wearables and Dementia Support
Can Brilliant Labs’ Frame / Halo Curb Veteran Talent Loss and Strengthen DX Organizations?
【AI Wearables for Dementia Support】
AI wearables may support dementia beyond treatment—helping with work, decisions, and communication.
Brilliant Labs’ Frame/Halo as “cognitive prosthetics” could reduce execution breakdowns and support autonomy.
09.01.2026 04:36 — 👍 2 🔁 1 💬 0 📌 0
The Great Debate Over the Brain’s “Glymphatic System”
When Does Our Brain Get Washed?
What if the brain doesn’t clean itself mainly during sleep?
Recent neuroscience is challenging the long-held theory of the glymphatic system.
I summarize the growing debate and its implications for brain health and dementia.
medium.com/@kosaku.okam...
06.01.2026 06:29 — 👍 1 🔁 0 💬 0 📌 0
Solving Dementia Care Challenges: The Potential of “N-Body Problem”
The field of dementia care now stands at a major turning point.
Accelerating staff shortages, increasingly diverse frontline personnel, and…
Dementia care is at a turning point.
What if AI could help decide when and how much to intervene—without taking away autonomy?
I explored the potential of the N-Body Problem as a new paradigm for dementia care.
👉 medium.com/@kosaku.okam...
06.01.2026 06:21 — 👍 0 🔁 0 💬 0 📌 0
Co-Creating Ireland's Public Involvement in Open Research Roadmap
ENGAGED is building a national roadmap to shape public involvement in open research in Ireland. We believe that research can and does play an important role in tackling societal challenges.
Transforming how Alzheimer's disease is detected, diagnosed, prevented and treated across healthcare settings.
Website: www.ad-riddle.org
Funding: EU/IHI JU No. 101132933 @ihieurope.bsky.social
National resource & catalyst for change in Scotland's Digital Health and Social Care Sector. Funded by the Scottish Funding Council and Scottish Government. Organiser of @digiinventors.com
https://linktr.ee/dhiscotland
PhD, neuropsychology | Alzheimer’s disease, cognition, measurement, remote digital cognitie assessments
Assistant Professor of Psychological & Brain Sciences at Washington University in St. Louis
Director of the Wellbeing and Emotion across the Lifespan Lab (WELLab)
PhD Candidate, Yale @ Che Lab • WTI Grad Fellow, NSF GRFP • Systems x computational neuroscience, Alzheimer's disease, and astrocytes • Prev. UCLA and UCSF • More about me: https://www.vincenttse.com/
Professor of Neurology. Humanist. Mentor. Alzheimer’s disease research.
Psychology PhD student at The University of Sussex, currently looking into emotion regulation and healthcare engagement in dementia.
CIHR Postdoc Fellow at the MNI @theneuro.bsky.social | PhD @mrccbu.bsky.social in Cambridge | Cognitive control, Attention, Domain-general brain networks | Multimodal neuroimaging | Gates Cambridge Scholar
Assoc Prof of Neurology, Harvard Medical School, Clinical Neuropsychologist, Mass General Brigham, researcher in digital cognition in preclinical Alzheimer's disease
Clinical and academic SLT working to improve care for those living with dementia
Cognitive-Communication in Aging and Neurogenic Disorders Laboratory (CCANDL) led by Dr. Kimberly Mueller at UW-Madison. Working to improve interventions for Alzheimer's & related disorders through early diagnosis of speech and language impairments. #ADRD
DETERMIND is an ambitious research project funded by the NIHR Three Schools’ Dementia Research Programme that aims to find out how we can make dementia care and outcomes in the UK more equal. https://determind.org
Post-doc @goteborgsuni | former post-doc @LundUniversity
| former PhD student @AlzheimerAms | cognition, imaging and fluid biomarkers in #AD | 🏴🇳🇱🇸🇪
Neurogenetics lab investigating Parkinson's disease, Lewy body dementia, and rare parkinsonian disorders 🧠🧬
Mayo Clinic, Jacksonville
https://www.mayo.edu/research/labs/parkinsons-disease/overview
Neuropathology Postdoc Researcher @KU_Leuven @neuropatho_lab 🧠 | Passionate about all things neuropathology | Alzheimer’s Disease | LATE🔬
Scientist and hockey player | studying CTE & Alzheimer's disease neuropathology @ Centre for Brain Research, UOA in Auckland NZ | Former captain of the #NZIceFernz
Neuroscientist, Neurologist, and Aging Researcher at UCSF
Physician-scientist with a passion for understanding how the brain works.
Professor. Washington University School of Medicine. Genomics, stem cell models, molecular mechanisms of AD and other tauopathies. She/her.
www.karchlab.wustl.edu
